Peripheral T-cell lymphoma (PTCL) - brentuximab vedotin - initial authority application form (PB314)

Use this form to apply for initial PBS-subsidised treatment with brentuximab vedotin for peripheral T-cell lymphoma.

Page last updated: 18 June 2024.
QC 55346